Dengue antibody prevalence in German travelers

Emerging Infectious Diseases

Volumn 11, Issue 5, 2005, Pages 762-765

  Wichmann, Ole ^a,d   Lauschke, Annekathrin ^a   Frank, Christina ^b   Shu, Pei Yun ^c   Niedrig, Matthias ^b   Huang, Jyh Hsiung ^c   Stark, Klaus ^b   Jelinek, Tomas ^a  

^a Universidade Nova de Lisboa   (Portugal)

^b ROBERT KOCH INSTITUTE   (Germany)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d Outpatient Department   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHILD; DENGUE; DENGUE VIRUS; DISEASE MARKER; EPIDEMIC; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; SERODIAGNOSIS; SEROEPIDEMIOLOGY; SEROTYPING; TOURISM; TRAVEL; VIRUS INFECTIVITY;

EID: 17844403275     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1105.050097     Document Type: Article

References (15)

1. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324:1563-6.
2. Jelinek T, Mühlberger N, Harms G, Corachan M, Grobusch MP, Knobloch J, et al. Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis. 2002;35:1047-52.
3. Lindbäck H, Lindbäck J, Tegnell A, Janzon R, Vene S, Ekdahl K. Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis. 2003;9:438-42.
4. Frank C, Schöneberg I, Krause G, Claus H, Ammon A, Stark K. Increase in imported dengue, Germany, 2001-2002. Emerg Infect Dis. 2004;10:903-6.
5. Nimmannitya S. Clinical manifestations of dengue/dengue haemorrhagic fever. In: World Health Organization, Regional Office for South-East Asia. Monograph on dengue/dengue haemorrhagic fever. Regional publication no. 22. New Delhi: The Organization; 1993. p. 48-54.
6. Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis. 1999;5:824-7.
7. Cobelens FGJ, Groen J, Osterhaus ADME, Leentvaar-Kuipers A, Wertheim-van Dillen PME, Kager PA. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health. 2002;7:331-8.
8. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis. 1997;176:322-30.
9. Wichmann O, Mühlberger N, Jelinek T. Dengue - the underestimated risk in travellers. Dengue Bulletin. 2003;27:126-37.
10. Barbazan P, Yoksan S, Gonzalez JP. Dengue hemorrhagic fever epidemiology in Thailand: description and forecasting of epidemics. Microbes Infect. 2002;4:699-705.
11. Shu PY, Chen LK, Chang SF, Sue CL, Chien LJ, Chin C, et al. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infection. Clin Diagn Lab Immunol. 2003;10:622-30.
12. Shu PY, Chen LK, Chang SF, Sue CL, Chien LJ, Chin C, et al. Dengue virus serotyping based on envelope/membrane (E/M) and nonstructural protein NS1 serotype-specific capture immunoglobulin M (IgM) enzyme-linked immunosorbent assays (ELISA). J Clin Microbiol. 2004;42:2489-94.
13. Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Dung NM, Kneen R, et al. Rapid serological diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg. 1999;60:693-8.
14. Schwartz E, Moskovitz A, Potasman I, Peri G, Grossmann Z, Alkan ML. Changing epidemiology of dengue fever in travellers to Thailand. Eur J Clin Microbiol Infect Dis. 2000;19:784-6.
15. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-96.